Klotho Neurosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Klotho Neurosciences, Inc. (KLTO) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.060.000.080.300.33
Cash & Short-Term Investments0.060.000.080.300.33
Accounts Receivable0.000.000.250.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.090.000.000.000.00
Total Current Assets0.160.010.330.300.33
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.00
Intangible Assets2.302.192.210.740.74
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets2.302.192.210.740.00
Total Assets2.462.192.541.041.07
Current Liabilities
Accounts Payable0.060.150.010.020.00
Short-Term Debt0.271.471.350.000.00
Accrued Liabilities0.910.000.000.000.00
Other Current Liabilities0.910.000.000.000.00
Total Current Liabilities1.251.621.360.020.00
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.00
Other Non-Current Liabilities0.020.000.000.000.00
Total Non-Current Liabilities0.020.000.000.000.00
Total Liabilities1.271.621.360.020.00
Stockholders' Equity
Common Stock0.000.000.100.100.00
Retained Earnings-10.56-3.92-3.22-2.62-1.51
Accumulated Other Comprehensive Income0.000.000.750.000.00
Additional Paid-in Capital11.754.493.543.540.00
Shares Outstanding27.0815.1315.1315.130.00
Total Stockholders' Equity1.190.571.181.031.07
Total Liabilities & Equity2.462.192.541.040.00